We demonstrate that this reduced expression of BLMH inversely correlates with expression of the chemokines CXCL8 and GROα in lesions from AD patients in a majority of the clinical studies analysed, a difference not seen in healthy individuals. This evidence concerns the gene CXCL1 and Alzheimer disease.